ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04060	Cytokine-cytokine receptor interaction	4/26	295/8135	0.01349	0.3371	0.3111	THPO/ACVR2A/TNFRSF9/CCR7	4
KEGG	hsa04022	cGMP-PKG signaling pathway	3/26	167/8135	0.01562	0.3371	0.3111	PPP1R12A/PIK3R5/ADRA2B	3
KEGG	hsa05133	Pertussis	2/26	76/8135	0.02422	0.3371	0.3111	C1QA/C3	2
KEGG	hsa04510	Focal adhesion	3/26	201/8135	0.02544	0.3371	0.3111	PPP1R12A/CCND2/COL9A2	3
KEGG	hsa04610	Complement and coagulation cascades	2/26	85/8135	0.02981	0.3371	0.3111	C1QA/C3	2
KEGG	hsa04512	ECM-receptor interaction	2/26	88/8135	0.03178	0.3371	0.3111	FRAS1/COL9A2	2
KEGG	hsa05171	Coronavirus disease - COVID-19	3/26	232/8135	0.03673	0.3371	0.3111	OAS2/C1QA/C3	3
KEGG	hsa05150	Staphylococcus aureus infection	2/26	96/8135	0.03728	0.3371	0.3111	C1QA/C3	2
KEGG	hsa04640	Hematopoietic cell lineage	2/26	99/8135	0.03942	0.3371	0.3111	CD1B/THPO	2
KEGG	hsa05142	Chagas disease	2/26	102/8135	0.04162	0.3371	0.3111	C1QA/C3	2
KEGG	hsa04611	Platelet activation	2/26	124/8135	0.05905	0.4043	0.3731	PPP1R12A/PIK3R5	2
KEGG	hsa05322	Systemic lupus erythematosus	2/26	136/8135	0.06946	0.4043	0.3731	C1QA/C3	2
KEGG	hsa05162	Measles	2/26	139/8135	0.07215	0.4043	0.3731	OAS2/CCND2	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	2/26	139/8135	0.07215	0.4043	0.3731	ACVR2A/NFE2L2	2
KEGG	hsa04936	Alcoholic liver disease	2/26	142/8135	0.07488	0.4043	0.3731	C1QA/C3	2
KEGG	hsa04921	Oxytocin signaling pathway	2/26	154/8135	0.08611	0.4359	0.4022	PPP1R12A/PIK3R5	2
KEGG	hsa04630	JAK-STAT signaling pathway	2/26	162/8135	0.09387	0.4472	0.4127	THPO/CCND2	2
KEGG	hsa04151	PI3K-Akt signaling pathway	3/26	354/8135	0.1016	0.4538	0.4187	PIK3R5/CCND2/COL9A2	3
KEGG	hsa04062	Chemokine signaling pathway	2/26	192/8135	0.1246	0.4538	0.4187	PIK3R5/CCR7	2
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	2/26	194/8135	0.1268	0.4538	0.4187	PIK3R5/C3	2
KEGG	hsa03022	Basal transcription factors	1/26	45/8135	0.1345	0.4538	0.4187	ERCC2	1
KEGG	hsa05169	Epstein-Barr virus infection	2/26	202/8135	0.1354	0.4538	0.4187	OAS2/CCND2	2
KEGG	hsa05203	Viral carcinogenesis	2/26	204/8135	0.1376	0.4538	0.4187	C3/CCND2	2
KEGG	hsa00620	Pyruvate metabolism	1/26	47/8135	0.1401	0.4538	0.4187	ACYP1	1
KEGG	hsa03420	Nucleotide excision repair	1/26	47/8135	0.1401	0.4538	0.4187	ERCC2	1
KEGG	hsa04340	Hedgehog signaling pathway	1/26	56/8135	0.1646	0.4992	0.4606	CCND2	1
KEGG	hsa05134	Legionellosis	1/26	57/8135	0.1673	0.4992	0.4606	C3	1
KEGG	hsa00310	Lysine degradation	1/26	63/8135	0.1833	0.4992	0.4606	PRDM7	1
KEGG	hsa05131	Shigellosis	2/26	247/8135	0.1861	0.4992	0.4606	RRAGD/C3	2
KEGG	hsa00830	Retinol metabolism	1/26	68/8135	0.1963	0.4992	0.4606	RDH8	1
KEGG	hsa04917	Prolactin signaling pathway	1/26	70/8135	0.2015	0.4992	0.4606	CCND2	1
KEGG	hsa05168	Herpes simplex virus 1 infection	3/26	495/8135	0.2083	0.4992	0.4606	ZNF714/OAS2/C3	3
KEGG	hsa04115	p53 signaling pathway	1/26	73/8135	0.2092	0.4992	0.4606	CCND2	1
KEGG	hsa05140	Leishmaniasis	1/26	77/8135	0.2194	0.4992	0.4606	C3	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/26	77/8135	0.2194	0.4992	0.4606	DES	1
KEGG	hsa04721	Synaptic vesicle cycle	1/26	78/8135	0.2219	0.4992	0.4606	RAB3A	1
KEGG	hsa04146	Peroxisome	1/26	82/8135	0.2319	0.5035	0.4646	PEX10	1
KEGG	hsa04911	Insulin secretion	1/26	86/8135	0.2418	0.5035	0.4646	RAB3A	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/26	90/8135	0.2515	0.5035	0.4646	DES	1
KEGG	hsa04350	TGF-beta signaling pathway	1/26	94/8135	0.2611	0.5035	0.4646	ACVR2A	1
KEGG	hsa05414	Dilated cardiomyopathy	1/26	96/8135	0.2659	0.5035	0.4646	DES	1
KEGG	hsa00564	Glycerophospholipid metabolism	1/26	98/8135	0.2707	0.5035	0.4646	LPGAT1	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/26	100/8135	0.2754	0.5035	0.4646	CCR7	1
KEGG	hsa05146	Amoebiasis	1/26	102/8135	0.28	0.5035	0.4646	CD1B	1
KEGG	hsa04974	Protein digestion and absorption	1/26	103/8135	0.2824	0.5035	0.4646	COL9A2	1
KEGG	hsa05165	Human papillomavirus infection	2/26	331/8135	0.2859	0.5035	0.4646	CCND2/COL9A2	2
KEGG	hsa05145	Toxoplasmosis	1/26	112/8135	0.303	0.5137	0.474	PIK3R5	1
KEGG	hsa04725	Cholinergic synapse	1/26	113/8135	0.3053	0.5137	0.474	PIK3R5	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	2/26	353/8135	0.3123	0.5137	0.474	C3/ADRA2B	2
KEGG	hsa04110	Cell cycle	1/26	126/8135	0.334	0.5137	0.474	CCND2	1
KEGG	hsa04068	FoxO signaling pathway	1/26	131/8135	0.3448	0.5137	0.474	CCND2	1
KEGG	hsa04270	Vascular smooth muscle contraction	1/26	134/8135	0.3511	0.5137	0.474	PPP1R12A	1
KEGG	hsa04371	Apelin signaling pathway	1/26	139/8135	0.3616	0.5137	0.474	PIK3R5	1
KEGG	hsa04140	Autophagy - animal	1/26	141/8135	0.3657	0.5137	0.474	RRAGD	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	1/26	143/8135	0.3699	0.5137	0.474	ACVR2A	1
KEGG	hsa04072	Phospholipase D signaling pathway	1/26	148/8135	0.38	0.5137	0.474	PIK3R5	1
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	1/26	150/8135	0.3841	0.5137	0.474	PIK3R5	1
KEGG	hsa04145	Phagosome	1/26	152/8135	0.3881	0.5137	0.474	C3	1
KEGG	hsa04150	mTOR signaling pathway	1/26	156/8135	0.396	0.5137	0.474	RRAGD	1
KEGG	hsa04218	Cellular senescence	1/26	156/8135	0.396	0.5137	0.474	CCND2	1
KEGG	hsa04390	Hippo signaling pathway	1/26	157/8135	0.398	0.5137	0.474	CCND2	1
KEGG	hsa05160	Hepatitis C	1/26	157/8135	0.398	0.5137	0.474	OAS2	1
KEGG	hsa04310	Wnt signaling pathway	1/26	167/8135	0.4173	0.5137	0.474	CCND2	1
KEGG	hsa05225	Hepatocellular carcinoma	1/26	168/8135	0.4192	0.5137	0.474	NFE2L2	1
KEGG	hsa04530	Tight junction	1/26	169/8135	0.4211	0.5137	0.474	CD1B	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	1/26	171/8135	0.4249	0.5137	0.474	NFE2L2	1
KEGG	hsa05164	Influenza A	1/26	171/8135	0.4249	0.5137	0.474	OAS2	1
KEGG	hsa05152	Tuberculosis	1/26	180/8135	0.4416	0.526	0.4853	C3	1
KEGG	hsa04621	NOD-like receptor signaling pathway	1/26	184/8135	0.4489	0.5269	0.4862	OAS2	1
KEGG	hsa04613	Neutrophil extracellular trap formation	1/26	190/8135	0.4596	0.5303	0.4893	C3	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/26	193/8135	0.4649	0.5303	0.4893	CCND2	1
KEGG	hsa05205	Proteoglycans in cancer	1/26	205/8135	0.4855	0.5419	0.5	PPP1R12A	1
KEGG	hsa05417	Lipid and atherosclerosis	1/26	215/8135	0.5022	0.5419	0.5	NFE2L2	1
KEGG	hsa04810	Regulation of actin cytoskeleton	1/26	218/8135	0.5071	0.5419	0.5	PPP1R12A	1
KEGG	hsa04024	cAMP signaling pathway	1/26	221/8135	0.5119	0.5419	0.5	PPP1R12A	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/26	222/8135	0.5135	0.5419	0.5	CCND2	1
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	1/26	223/8135	0.5151	0.5419	0.5	NFE2L2	1
KEGG	hsa04714	Thermogenesis	1/26	232/8135	0.5293	0.5496	0.5071	SLC25A20	1
KEGG	hsa05012	Parkinson disease	1/26	266/8135	0.5793	0.5939	0.548	NFE2L2	1
KEGG	hsa05020	Prion disease	1/26	273/8135	0.5889	0.5963	0.5501	C1QA	1
KEGG	hsa05206	MicroRNAs in cancer	1/26	310/8135	0.6364	0.6364	0.5872	CCND2	1